Kinetics and Specificity of Human Liver Aldehyde Dehydrogenases toward Aliphatic, Aromatic, and Fused Polycyclic Aldehydes

Human mitochondrial aldehyde dehydrogenase (ALDH-2) has a K m for acetaldehyde that is 900-fold lower than that for the cytosolic isozyme, ALDH-1. An increase in aliphatic aldehyde chain length decreases the ALDH-2 K m by up to 10-fold but decreases that of ALDH-1 by 5 orders of magnitude. As a cons...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biochemistry (Easton) 1996-04, Vol.35 (14), p.4457-4467
1. Verfasser: Klyosov, Anatole A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 4467
container_issue 14
container_start_page 4457
container_title Biochemistry (Easton)
container_volume 35
creator Klyosov, Anatole A
description Human mitochondrial aldehyde dehydrogenase (ALDH-2) has a K m for acetaldehyde that is 900-fold lower than that for the cytosolic isozyme, ALDH-1. An increase in aliphatic aldehyde chain length decreases the ALDH-2 K m by up to 10-fold but decreases that of ALDH-1 by 5 orders of magnitude. As a consequence, the K m of ALDH-1 for decanal is 8 times lower than that of ALDH-2, i.e. 2.9 ± 0.4 and 22 ± 3 nM, respectively. Determination of these low K m values required kinetic analysis of the simultaneous enzymatic conversion of two aldehyde substrates, an approach also applied to aromatic and fused polycyclic aldehydes. For most of these substrates, maximum velocities are 5−100 times lower than those for acetaldehyde. Addition of one of these tight-binding, slow-turnover substrates to a reaction mixture containing ALDH, NAD+, and a “reference” aldehyde substrate (e.g. acetaldehyde) blocks the principal (reference) enzymatic reaction temporarily and reversibly. Once the first substrate is converted to product, the enzyme can act on the reference substrate. In terms of apparent affinity and blocking capacity, naphthalene and phenanthrene aldehydes were the most potent effectors. Other aromatic and fused polycyclic and heterocyclic aldehydes, as well as derivatives of coumarin, quinoline, indole, and pyridine, are tight-binding, slow-turnover substrates for ALDH-2 and relatively weak inhibitors of ALDH-1. The hydrophobicity of substituents of benzaldehydes, and particularly of naphthaldehydes, correlates with their binding constants toward ALDH-2. Vitamin A1 aldehydes are specific natural substrates for ALDH-1; at pH 7.5, for all-trans- and 13-cis-retinal, K m = 1.1 and 0.37 μM, respectively, and k cat/K m is 50−100 times higher than that for acetaldehyde. At the same time, the retinals are inhibitors of ALDH-2, all-trans-retinal being a particularly potent inhibitor (competitive K i = 43 nM, noncompetitive K i = 316 nM). These properties suggest that all-trans-retinal is a possible regulatory compound for ALDH-2 in vivo. The data in general point to specialized roles for both major human liver ALDH isozymes in the oxidation of bulky/hydrophobic natural compounds, with K m values in the low nanomolar range.
doi_str_mv 10.1021/bi9521102
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_77978294</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>77978294</sourcerecordid><originalsourceid>FETCH-LOGICAL-a414t-27a1c45a59151d667450a261f171c0a3032147bc81dd616f2a39996b6e9bbc943</originalsourceid><addsrcrecordid>eNptkE1v1DAQhi0EKkvhwA9A8gUkpAY8jj_Wx2VhadWVqNTC1XJsh7ok8WIntOmvJ0tWe-I0M3ofPSO9CL0G8gEIhY9VUJzCtD5BC-CUFEwp_hQtCCGioEqQ5-hFznfTyYhkJ-hkKQgHxRfo8TJ0vg82Y9M5fL3zNtTBhn7EscbnQ2s6vA1_fMKrxvnb0Xn8eT9S_Ok7k33Gfbw3yU1x2N2aSXSGVym287ZXbobsHb6KzWhH2wR7FOWX6FltmuxfHeYp-r75crM-L7bfvl6sV9vCMGB9QaUBy7jhCjg4ISTjxFABNUiwxJSkpMBkZZfgnABRU1MqpUQlvKoqq1h5it7N3l2Kvwefe92GbH3TmM7HIWsplVzSf-D7GbQp5px8rXcptCaNGoje96yPPU_sm4N0qFrvjuSh2Ckv5jzk3j8cY5N-aSFLyfXN1bX-IajYrtVGf5r4tzNvbNZ3cUjdVMl__v4Fe8OSUQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>77978294</pqid></control><display><type>article</type><title>Kinetics and Specificity of Human Liver Aldehyde Dehydrogenases toward Aliphatic, Aromatic, and Fused Polycyclic Aldehydes</title><source>MEDLINE</source><source>American Chemical Society Journals</source><creator>Klyosov, Anatole A</creator><creatorcontrib>Klyosov, Anatole A</creatorcontrib><description>Human mitochondrial aldehyde dehydrogenase (ALDH-2) has a K m for acetaldehyde that is 900-fold lower than that for the cytosolic isozyme, ALDH-1. An increase in aliphatic aldehyde chain length decreases the ALDH-2 K m by up to 10-fold but decreases that of ALDH-1 by 5 orders of magnitude. As a consequence, the K m of ALDH-1 for decanal is 8 times lower than that of ALDH-2, i.e. 2.9 ± 0.4 and 22 ± 3 nM, respectively. Determination of these low K m values required kinetic analysis of the simultaneous enzymatic conversion of two aldehyde substrates, an approach also applied to aromatic and fused polycyclic aldehydes. For most of these substrates, maximum velocities are 5−100 times lower than those for acetaldehyde. Addition of one of these tight-binding, slow-turnover substrates to a reaction mixture containing ALDH, NAD+, and a “reference” aldehyde substrate (e.g. acetaldehyde) blocks the principal (reference) enzymatic reaction temporarily and reversibly. Once the first substrate is converted to product, the enzyme can act on the reference substrate. In terms of apparent affinity and blocking capacity, naphthalene and phenanthrene aldehydes were the most potent effectors. Other aromatic and fused polycyclic and heterocyclic aldehydes, as well as derivatives of coumarin, quinoline, indole, and pyridine, are tight-binding, slow-turnover substrates for ALDH-2 and relatively weak inhibitors of ALDH-1. The hydrophobicity of substituents of benzaldehydes, and particularly of naphthaldehydes, correlates with their binding constants toward ALDH-2. Vitamin A1 aldehydes are specific natural substrates for ALDH-1; at pH 7.5, for all-trans- and 13-cis-retinal, K m = 1.1 and 0.37 μM, respectively, and k cat/K m is 50−100 times higher than that for acetaldehyde. At the same time, the retinals are inhibitors of ALDH-2, all-trans-retinal being a particularly potent inhibitor (competitive K i = 43 nM, noncompetitive K i = 316 nM). These properties suggest that all-trans-retinal is a possible regulatory compound for ALDH-2 in vivo. The data in general point to specialized roles for both major human liver ALDH isozymes in the oxidation of bulky/hydrophobic natural compounds, with K m values in the low nanomolar range.</description><identifier>ISSN: 0006-2960</identifier><identifier>EISSN: 1520-4995</identifier><identifier>DOI: 10.1021/bi9521102</identifier><identifier>PMID: 8605195</identifier><language>eng</language><publisher>United States: American Chemical Society</publisher><subject>Acetaldehyde - metabolism ; Aldehyde Dehydrogenase - antagonists &amp; inhibitors ; Aldehyde Dehydrogenase - metabolism ; Aldehydes - chemistry ; Aldehydes - metabolism ; Benzaldehydes - metabolism ; Binding, Competitive ; Catalysis ; Cytosol - enzymology ; Electrochemistry ; Enzyme Inhibitors - pharmacology ; Humans ; In Vitro Techniques ; Isoenzymes - antagonists &amp; inhibitors ; Isoenzymes - metabolism ; Kinetics ; Liver - enzymology ; Mitochondria, Liver - enzymology ; Molecular Structure ; Retinaldehyde - metabolism ; Retinaldehyde - pharmacology ; Substrate Specificity</subject><ispartof>Biochemistry (Easton), 1996-04, Vol.35 (14), p.4457-4467</ispartof><rights>Copyright © 1996 American Chemical Society</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a414t-27a1c45a59151d667450a261f171c0a3032147bc81dd616f2a39996b6e9bbc943</citedby><cites>FETCH-LOGICAL-a414t-27a1c45a59151d667450a261f171c0a3032147bc81dd616f2a39996b6e9bbc943</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/bi9521102$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/bi9521102$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>314,776,780,2752,27053,27901,27902,56713,56763</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8605195$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Klyosov, Anatole A</creatorcontrib><title>Kinetics and Specificity of Human Liver Aldehyde Dehydrogenases toward Aliphatic, Aromatic, and Fused Polycyclic Aldehydes</title><title>Biochemistry (Easton)</title><addtitle>Biochemistry</addtitle><description>Human mitochondrial aldehyde dehydrogenase (ALDH-2) has a K m for acetaldehyde that is 900-fold lower than that for the cytosolic isozyme, ALDH-1. An increase in aliphatic aldehyde chain length decreases the ALDH-2 K m by up to 10-fold but decreases that of ALDH-1 by 5 orders of magnitude. As a consequence, the K m of ALDH-1 for decanal is 8 times lower than that of ALDH-2, i.e. 2.9 ± 0.4 and 22 ± 3 nM, respectively. Determination of these low K m values required kinetic analysis of the simultaneous enzymatic conversion of two aldehyde substrates, an approach also applied to aromatic and fused polycyclic aldehydes. For most of these substrates, maximum velocities are 5−100 times lower than those for acetaldehyde. Addition of one of these tight-binding, slow-turnover substrates to a reaction mixture containing ALDH, NAD+, and a “reference” aldehyde substrate (e.g. acetaldehyde) blocks the principal (reference) enzymatic reaction temporarily and reversibly. Once the first substrate is converted to product, the enzyme can act on the reference substrate. In terms of apparent affinity and blocking capacity, naphthalene and phenanthrene aldehydes were the most potent effectors. Other aromatic and fused polycyclic and heterocyclic aldehydes, as well as derivatives of coumarin, quinoline, indole, and pyridine, are tight-binding, slow-turnover substrates for ALDH-2 and relatively weak inhibitors of ALDH-1. The hydrophobicity of substituents of benzaldehydes, and particularly of naphthaldehydes, correlates with their binding constants toward ALDH-2. Vitamin A1 aldehydes are specific natural substrates for ALDH-1; at pH 7.5, for all-trans- and 13-cis-retinal, K m = 1.1 and 0.37 μM, respectively, and k cat/K m is 50−100 times higher than that for acetaldehyde. At the same time, the retinals are inhibitors of ALDH-2, all-trans-retinal being a particularly potent inhibitor (competitive K i = 43 nM, noncompetitive K i = 316 nM). These properties suggest that all-trans-retinal is a possible regulatory compound for ALDH-2 in vivo. The data in general point to specialized roles for both major human liver ALDH isozymes in the oxidation of bulky/hydrophobic natural compounds, with K m values in the low nanomolar range.</description><subject>Acetaldehyde - metabolism</subject><subject>Aldehyde Dehydrogenase - antagonists &amp; inhibitors</subject><subject>Aldehyde Dehydrogenase - metabolism</subject><subject>Aldehydes - chemistry</subject><subject>Aldehydes - metabolism</subject><subject>Benzaldehydes - metabolism</subject><subject>Binding, Competitive</subject><subject>Catalysis</subject><subject>Cytosol - enzymology</subject><subject>Electrochemistry</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>Humans</subject><subject>In Vitro Techniques</subject><subject>Isoenzymes - antagonists &amp; inhibitors</subject><subject>Isoenzymes - metabolism</subject><subject>Kinetics</subject><subject>Liver - enzymology</subject><subject>Mitochondria, Liver - enzymology</subject><subject>Molecular Structure</subject><subject>Retinaldehyde - metabolism</subject><subject>Retinaldehyde - pharmacology</subject><subject>Substrate Specificity</subject><issn>0006-2960</issn><issn>1520-4995</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNptkE1v1DAQhi0EKkvhwA9A8gUkpAY8jj_Wx2VhadWVqNTC1XJsh7ok8WIntOmvJ0tWe-I0M3ofPSO9CL0G8gEIhY9VUJzCtD5BC-CUFEwp_hQtCCGioEqQ5-hFznfTyYhkJ-hkKQgHxRfo8TJ0vg82Y9M5fL3zNtTBhn7EscbnQ2s6vA1_fMKrxvnb0Xn8eT9S_Ok7k33Gfbw3yU1x2N2aSXSGVym287ZXbobsHb6KzWhH2wR7FOWX6FltmuxfHeYp-r75crM-L7bfvl6sV9vCMGB9QaUBy7jhCjg4ISTjxFABNUiwxJSkpMBkZZfgnABRU1MqpUQlvKoqq1h5it7N3l2Kvwefe92GbH3TmM7HIWsplVzSf-D7GbQp5px8rXcptCaNGoje96yPPU_sm4N0qFrvjuSh2Ckv5jzk3j8cY5N-aSFLyfXN1bX-IajYrtVGf5r4tzNvbNZ3cUjdVMl__v4Fe8OSUQ</recordid><startdate>19960409</startdate><enddate>19960409</enddate><creator>Klyosov, Anatole A</creator><general>American Chemical Society</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19960409</creationdate><title>Kinetics and Specificity of Human Liver Aldehyde Dehydrogenases toward Aliphatic, Aromatic, and Fused Polycyclic Aldehydes</title><author>Klyosov, Anatole A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a414t-27a1c45a59151d667450a261f171c0a3032147bc81dd616f2a39996b6e9bbc943</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>Acetaldehyde - metabolism</topic><topic>Aldehyde Dehydrogenase - antagonists &amp; inhibitors</topic><topic>Aldehyde Dehydrogenase - metabolism</topic><topic>Aldehydes - chemistry</topic><topic>Aldehydes - metabolism</topic><topic>Benzaldehydes - metabolism</topic><topic>Binding, Competitive</topic><topic>Catalysis</topic><topic>Cytosol - enzymology</topic><topic>Electrochemistry</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>Humans</topic><topic>In Vitro Techniques</topic><topic>Isoenzymes - antagonists &amp; inhibitors</topic><topic>Isoenzymes - metabolism</topic><topic>Kinetics</topic><topic>Liver - enzymology</topic><topic>Mitochondria, Liver - enzymology</topic><topic>Molecular Structure</topic><topic>Retinaldehyde - metabolism</topic><topic>Retinaldehyde - pharmacology</topic><topic>Substrate Specificity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Klyosov, Anatole A</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Biochemistry (Easton)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Klyosov, Anatole A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Kinetics and Specificity of Human Liver Aldehyde Dehydrogenases toward Aliphatic, Aromatic, and Fused Polycyclic Aldehydes</atitle><jtitle>Biochemistry (Easton)</jtitle><addtitle>Biochemistry</addtitle><date>1996-04-09</date><risdate>1996</risdate><volume>35</volume><issue>14</issue><spage>4457</spage><epage>4467</epage><pages>4457-4467</pages><issn>0006-2960</issn><eissn>1520-4995</eissn><abstract>Human mitochondrial aldehyde dehydrogenase (ALDH-2) has a K m for acetaldehyde that is 900-fold lower than that for the cytosolic isozyme, ALDH-1. An increase in aliphatic aldehyde chain length decreases the ALDH-2 K m by up to 10-fold but decreases that of ALDH-1 by 5 orders of magnitude. As a consequence, the K m of ALDH-1 for decanal is 8 times lower than that of ALDH-2, i.e. 2.9 ± 0.4 and 22 ± 3 nM, respectively. Determination of these low K m values required kinetic analysis of the simultaneous enzymatic conversion of two aldehyde substrates, an approach also applied to aromatic and fused polycyclic aldehydes. For most of these substrates, maximum velocities are 5−100 times lower than those for acetaldehyde. Addition of one of these tight-binding, slow-turnover substrates to a reaction mixture containing ALDH, NAD+, and a “reference” aldehyde substrate (e.g. acetaldehyde) blocks the principal (reference) enzymatic reaction temporarily and reversibly. Once the first substrate is converted to product, the enzyme can act on the reference substrate. In terms of apparent affinity and blocking capacity, naphthalene and phenanthrene aldehydes were the most potent effectors. Other aromatic and fused polycyclic and heterocyclic aldehydes, as well as derivatives of coumarin, quinoline, indole, and pyridine, are tight-binding, slow-turnover substrates for ALDH-2 and relatively weak inhibitors of ALDH-1. The hydrophobicity of substituents of benzaldehydes, and particularly of naphthaldehydes, correlates with their binding constants toward ALDH-2. Vitamin A1 aldehydes are specific natural substrates for ALDH-1; at pH 7.5, for all-trans- and 13-cis-retinal, K m = 1.1 and 0.37 μM, respectively, and k cat/K m is 50−100 times higher than that for acetaldehyde. At the same time, the retinals are inhibitors of ALDH-2, all-trans-retinal being a particularly potent inhibitor (competitive K i = 43 nM, noncompetitive K i = 316 nM). These properties suggest that all-trans-retinal is a possible regulatory compound for ALDH-2 in vivo. The data in general point to specialized roles for both major human liver ALDH isozymes in the oxidation of bulky/hydrophobic natural compounds, with K m values in the low nanomolar range.</abstract><cop>United States</cop><pub>American Chemical Society</pub><pmid>8605195</pmid><doi>10.1021/bi9521102</doi><tpages>11</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0006-2960
ispartof Biochemistry (Easton), 1996-04, Vol.35 (14), p.4457-4467
issn 0006-2960
1520-4995
language eng
recordid cdi_proquest_miscellaneous_77978294
source MEDLINE; American Chemical Society Journals
subjects Acetaldehyde - metabolism
Aldehyde Dehydrogenase - antagonists & inhibitors
Aldehyde Dehydrogenase - metabolism
Aldehydes - chemistry
Aldehydes - metabolism
Benzaldehydes - metabolism
Binding, Competitive
Catalysis
Cytosol - enzymology
Electrochemistry
Enzyme Inhibitors - pharmacology
Humans
In Vitro Techniques
Isoenzymes - antagonists & inhibitors
Isoenzymes - metabolism
Kinetics
Liver - enzymology
Mitochondria, Liver - enzymology
Molecular Structure
Retinaldehyde - metabolism
Retinaldehyde - pharmacology
Substrate Specificity
title Kinetics and Specificity of Human Liver Aldehyde Dehydrogenases toward Aliphatic, Aromatic, and Fused Polycyclic Aldehydes
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T08%3A32%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Kinetics%20and%20Specificity%20of%20Human%20Liver%20Aldehyde%20Dehydrogenases%20toward%20Aliphatic,%20Aromatic,%20and%20Fused%20Polycyclic%20Aldehydes&rft.jtitle=Biochemistry%20(Easton)&rft.au=Klyosov,%20Anatole%20A&rft.date=1996-04-09&rft.volume=35&rft.issue=14&rft.spage=4457&rft.epage=4467&rft.pages=4457-4467&rft.issn=0006-2960&rft.eissn=1520-4995&rft_id=info:doi/10.1021/bi9521102&rft_dat=%3Cproquest_cross%3E77978294%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=77978294&rft_id=info:pmid/8605195&rfr_iscdi=true